Dongsung Pharm (002210) — Cash Flow Reinvestment Rate
Dongsung Pharm (002210) has a Cash Flow Reinvestment Rate of 0.25x as of June 2025, reinvesting ₩1.07 Billion (capex ₩0.00 plus investments ₩-1.07 Billion) from operating cash flow of ₩4.20 Billion. Explore how much does Dongsung Pharm reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dongsung Pharm Cash Flow Reinvestment Rate (2010–2020)
Historical reinvestment intensity for Dongsung Pharm across 4 annual periods. Also explore 002210 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Dongsung Pharm (2010–2020)
Year-by-year capital reinvestment analysis for Dongsung Pharm. For live market cap and broader valuation context, see Dongsung Pharm (002210) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 2.51x | ₩12.56 Billion | ₩5.01 Billion | ₩6.92 Billion | ▼ -83.5% |
| 2018 | 15.21x | ₩21.19 Billion | ₩1.39 Billion | ₩2.13 Billion | ▲ +668.2% |
| 2017 | 1.98x | ₩3.56 Billion | ₩1.80 Billion | ₩3.00 Billion | ▲ +588.0% |
| 2010 | 0.29x | ₩1.06 Billion | ₩3.68 Billion | ₩847.33 Million | — |